Big Rock Partners Acquisition Corp.

closedW=S@11.50
NRXPSEC EDGARCIK: 0001719406|NRX Pharmaceuticals, Inc.•Pharmaceuticals

Capital Structure & Economics

Trust Size$50,000,000
Unit Price$10.00
Warrant Coverage-
Sponsor Promote20%

Implied Equity Architecture

Capital Allocation Baseline

Trust (100.0%)

Implied Dilution Drag

No Warrants / No Drag
Public Trust Allocation$50,000,000
Sponsor At-Risk CapitalN/A
Total Underwriting DiscountN/A
Trust Per Unit (Implied)$10.00
Sponsor Promote Allocation20%
Deal Lifecycle
IPO PricedOct 13, 2017
SearchingTarget Pending
Maturation Wall
May 24, 2021

Announced Target / M&A

  • Target CompanyNeuroRx, Inc.
  • SectorPharmaceuticals
  • Announced Deal Size$500,000,000

Board & Officers

  • Jonathan JavittCEO
  • Richard AckermanOfficer
  • Lori B. WittmanOfficer
  • Bennett KimOfficer
  • Michael FongOfficer
  • Stuart KoenigOfficer
  • Albert G. RexOfficer
  • Troy T. TaylorOfficer

Advanced Structuring Terms

Target SectorsPharmaceuticals

Syndicate & Advisors

Interactive Deal Modeling

Base financial constraints (Trust Size, Warrants, Promote) are pre-loaded into the calculation engines. Proceed to model implied dilution and advisory friction limits.

Dilution Cash Friction